drugset
drugset / Trial / NCT01193387

Comparison of Two Identical NN1250 Formulations in Healthy Volunteers

NCT01193387 ↗

Phase 1 Completed 26 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this clinical trial is to investigate if two identical formulations of NN1250 (insulin degludec, IDeg) have the same level of drug exposure to the body.

Timeline

Start
2010-08
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin degludec Protein / enzyme biologic — Subcutaneous

Indications

diabetes mellitus